KLP Kapitalforvaltning AS bought a new stake in Sotera Health (NASDAQ:SHC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 32,700 shares of the company's stock, valued at approximately $447,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Blue Trust Inc. lifted its holdings in Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after acquiring an additional 1,140 shares during the period. GAMMA Investing LLC lifted its stake in shares of Sotera Health by 37.5% in the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock valued at $56,000 after purchasing an additional 1,121 shares during the period. PNC Financial Services Group Inc. grew its position in Sotera Health by 39.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock worth $127,000 after buying an additional 2,627 shares during the period. Envestnet Portfolio Solutions Inc. increased its holdings in Sotera Health by 17.3% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company's stock valued at $217,000 after buying an additional 2,340 shares in the last quarter. Finally, Oak Thistle LLC purchased a new stake in shares of Sotera Health during the 4th quarter worth approximately $222,000. Hedge funds and other institutional investors own 91.03% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Barclays dropped their price objective on Sotera Health from $17.00 to $16.00 and set an "overweight" rating for the company in a research note on Friday, February 28th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $16.00.
Read Our Latest Analysis on SHC
Sotera Health Price Performance
Shares of SHC stock traded up $1.52 during trading hours on Wednesday, hitting $11.32. The company's stock had a trading volume of 2,108,387 shares, compared to its average volume of 1,192,308. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The business has a fifty day moving average of $12.28 and a 200-day moving average of $13.61. Sotera Health has a twelve month low of $9.61 and a twelve month high of $17.08. The stock has a market cap of $3.21 billion, a price-to-earnings ratio of 45.28 and a beta of 1.88.
Sotera Health Profile
(
Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Featured Stories

Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.